US 8771735
Immediate release dosage forms of sodium oxybate
granted A61KA61K31/19A61K9/2054
Quick answer
US patent 8771735 (Immediate release dosage forms of sodium oxybate) held by Jazz Pharmaceuticals, Inc. expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jazz Pharmaceuticals, Inc.
- Grant date
- Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/19, A61K9/2054, A61K9/282, A61K9/284